The most common side effects are mild digestive ones nausea, constipation, or acid reflux especially in the first weeks as your dose adjusts
Otherwise, serious adverse events were reported in ~6% of participants and were evenly distributed across tirzepatide and placebo groups
Available from: Brittany V B Johnson 1 , Mary Milstead 1 , Rachel Kreider 1 , Rachel Jones 1 Dietary supplement considerations during glucagon-like Peptide-1 receptor agonist treatment: A narrative review
If you experience significant pain, swelling, or persistent irritation, discontinue use and contact your provider
This guide provides clear, step-by-step instructions aligned with UK clinical guidance to help you use your GLP-1 medication correctly
True microdosing of GLP-1 receptor agonists would mean taking doses below 0.25 mg of semaglutide or below 2.5 mg of tirzepatide, often as low as 0.05 to 0.1 mg